Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Multiple Sclerosis

Free Subscription 03.06.2024 1 Arch Phys Med Rehabil 1 J Neurol 1 J Neurol Sci 1 Magn Reson Med 4 Mult Scler 1 Neurol Genet 1 PLoS One 1 Rev Neurol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arch Phys Med Rehabil

1. BAE M, Ku B, VanNostrand M, Kasser SL, et al
   Home-based Balance Training on Balance and Mobility in Persons with Multiple Sclerosis: A Systematic Review and Meta-analysis.
   Arch Phys Med Rehabil. 2024 May 27:S0003-9993(24)01015.
   PubMed         Abstract available
   
   

   
   J Neurol

2. PORTACCIO E, Betti M, De Meo E, Addazio I, et al
   Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.
   J Neurol. 2024 May 28. doi: 10.1007/s00415-024-12448.
   PubMed         Abstract available
   
   

   
   J Neurol Sci

3. PIEDRABUENA MA, Correale J, Fiol M, Marrodan M, et al
   Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry.
   J Neurol Sci. 2024;461:123052.
   PubMed         Abstract available
   
   

   
   Magn Reson Med

4. SHEN X, Caverzasi E, Yang Y, Liu X, et al
   3D balanced SSFP UTE MRI for multiple contrasts whole brain imaging.
   Magn Reson Med. 2024;92:702-714.
   PubMed         Abstract available
   
   

   
   Mult Scler

5. FOSTER MA, Prados F, Collorone S, Kanber B, et al
   Improving explanation of motor disability with diffusion-based graph metrics at onset of the first demyelinating event.
   Mult Scler. 2024;30:800-811.
   PubMed         Abstract available
   
   
6. MONTOBBIO N, Bovis F, Signori A, Ponzano M, et al
   Therapeutic lag: Is treatment effect delayed in progressive MS?
   Mult Scler. 2024;30:843-846.
   PubMed         Abstract available
   
   
7. PAPPOLLA A, Auger C, Sao-Aviles A, Tur C, et al
   Prediction of disease activity and treatment failure in relapsing-remitting MS patients initiating daily oral DMTs.
   Mult Scler. 2024 Mar 29:13524585241240653. doi: 10.1177/13524585241240653.
   PubMed         Abstract available
   
   
8. PFEUFFER S
   Psoriasisform dermatitis following anti-CD20 therapies: Immunologic lessons and management dilemmas.
   Mult Scler. 2024;30:897-898.
   PubMed        
   
   

   
   Neurol Genet

9. MISICKA E, Huang Y, Loomis S, Sadhu N, et al
   Adaptive and Innate Immunity Are Key Drivers of Age at Onset of Multiple Sclerosis.
   Neurol Genet. 2024;10:e200159.
   PubMed         Abstract available
   
   

   
   PLoS One

10. HARRISON DM, Allette YM, Zeng Y, Cohen A, et al
    Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance.
    PLoS One. 2024;19:e0300298.
    PubMed         Abstract available
    
    

    
    Rev Neurol

11. APARICIO-CASTRO E, Candeliere-Merlicco A, Maria Santa C, Villaverde-Gonzalez R, et al
    [Usefulness of the Beck depression inventory in the diagnosis of depressive disorders in multiple sclerosis].
    Rev Neurol. 2024;78:317-322.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.